BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 16481920)

  • 21. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.
    Sennoga CA; Kanbar E; Auboire L; Dujardin PA; Fouan D; Escoffre JM; Bouakaz A
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1031-1043. PubMed ID: 27892760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength.
    Maul TM; Dudgeon DD; Beste MT; Hammer DA; Lazo JS; Villanueva FS; Wagner WR
    Biotechnol Bioeng; 2010 Dec; 107(5):854-64. PubMed ID: 20665479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular imaging with targeted contrast ultrasound.
    Kaufmann BA; Lindner JR
    Curr Opin Biotechnol; 2007 Feb; 18(1):11-6. PubMed ID: 17241779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.
    Sirsi SR; Hernandez SL; Zielinski L; Blomback H; Koubaa A; Synder M; Homma S; Kandel JJ; Yamashiro DJ; Borden MA
    J Control Release; 2012 Jan; 157(2):224-34. PubMed ID: 21945680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relevance of contrast ultrasound with microbubbles in vascular medecine].
    Erdmann A; Ney B; Alatri A; Calanca L; Mazzolai L
    Rev Med Suisse; 2016 Dec; 12(542):2131-2134. PubMed ID: 28700167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications.
    Bekeredjian R; Katus HA; Kuecherer HF
    Ultraschall Med; 2006 Apr; 27(2):134-40. PubMed ID: 16612722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound Contrast: Gas Microbubbles in the Vasculature.
    Klibanov AL
    Invest Radiol; 2021 Jan; 56(1):50-61. PubMed ID: 33181574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound contrast agents as markers of vascularity and microcirculation.
    Greis C
    Clin Hemorheol Microcirc; 2009; 43(1-2):1-9. PubMed ID: 19713597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas.
    Bekeredjian R; Kroll RD; Fein E; Tinkov S; Coester C; Winter G; Katus HA; Kulaksiz H
    Ultrasound Med Biol; 2007 Oct; 33(10):1592-8. PubMed ID: 17618040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents.
    Barreiro O; Aguilar RJ; Tejera E; Megías D; de Torres-Alba F; Evangelista A; Sánchez-Madrid F
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):997-1005. PubMed ID: 19679288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents.
    Stieger SM; Dayton PA; Borden MA; Caskey CF; Griffey SM; Wisner ER; Ferrara KW
    Contrast Media Mol Imaging; 2008; 3(1):9-18. PubMed ID: 18335479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P85, Optison microbubbles and ultrasound cooperate in mediating plasmid DNA transfection in mouse skeletal muscles in vivo.
    Chen YC; Jiang LP; Liu NX; Wang ZH; Hong K; Zhang QP
    Ultrason Sonochem; 2011 Mar; 18(2):513-9. PubMed ID: 20863738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.
    Ferrara K; Pollard R; Borden M
    Annu Rev Biomed Eng; 2007; 9():415-47. PubMed ID: 17651012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound molecular imaging.
    Voigt JU
    Methods; 2009 Jun; 48(2):92-7. PubMed ID: 19324089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting and ultrasound imaging of microbubble-based contrast agents.
    Klibanov AL; Hughes MS; Villanueva FS; Jankowski RJ; Wagner WR; Wojdyla JK; Wible JH; Brandenburger GH
    MAGMA; 1999 Aug; 8(3):177-84. PubMed ID: 10504045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbubbles and ultrasound: from diagnosis to therapy.
    Dijkmans PA; Juffermans LJ; Musters RJ; van Wamel A; ten Cate FJ; van Gilst W; Visser CA; de Jong N; Kamp O
    Eur J Echocardiogr; 2004 Aug; 5(4):245-56. PubMed ID: 15219539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery.
    Chen ZY; Yang F; Lin Y; Zhang JS; Qiu RX; Jiang L; Zhou XX; Yu JX
    Curr Gene Ther; 2013 Aug; 13(4):250-74. PubMed ID: 23721204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase shift variance imaging - a new technique for destructive microbubble imaging.
    Siepmann M; Fokong S; Mienkina M; Lederle W; Kiessling F; Gätjens J; Schmitz G
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 May; 60(5):909-23. PubMed ID: 23661125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.